Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 4
2009 1
2010 2
2011 5
2012 3
2013 7
2014 5
2015 2
2016 7
2017 1
2018 2
2019 4
2020 6
2021 4
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Super-enhancers: drivers of cells' identities and cells' debacles.
Lavaud M, Tesfaye R, Lassous L, Brounais B, Baud'huin M, Verrecchia F, Lamoureux F, Georges S, Ory B. Lavaud M, et al. Among authors: lamoureux f. Epigenomics. 2024 Apr 8. doi: 10.2217/epi-2023-0409. Online ahead of print. Epigenomics. 2024. PMID: 38587919 Review.
Ewing sarcoma from molecular biology to the clinic.
Dupuy M, Lamoureux F, Mullard M, Postec A, Regnier L, Baud'huin M, Georges S, Brounais-Le Royer B, Ory B, Rédini F, Verrecchia F. Dupuy M, et al. Among authors: lamoureux f. Front Cell Dev Biol. 2023 Sep 11;11:1248753. doi: 10.3389/fcell.2023.1248753. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37752913 Free PMC article. Review.
Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells.
Tesfaye RA, Lavaud M, Charrier C, Brounais-Le Royer B, Cartron PF, Verrecchia F, Baud'huin M, Lamoureux F, Georges S, Ory B. Tesfaye RA, et al. Among authors: lamoureux f. Environ Health Perspect. 2023 Jun;131(6):67007. doi: 10.1289/EHP11690. Epub 2023 Jun 12. Environ Health Perspect. 2023. PMID: 37307168 Free PMC article.
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.
Urbain JL, Scott AM, Lee ST, Buscombe J, Weston C, Hatazawa J, Kinuya S, Singh B, Haidar M, Ross A, Lamoureux F, Kunikowska J, Wadsak W, Dierckx R, Paez D, Giammarile F, Lee KH, O JH, Moshe M, Louw L, More S, Nadel H, Lee D, Wahl R. Urbain JL, et al. Among authors: lamoureux f. J Nucl Med. 2023 Jun;64(6):986-991. doi: 10.2967/jnumed.123.265603. Epub 2023 May 4. J Nucl Med. 2023. PMID: 37142302 No abstract available.
Editorial: New therapies in the treatment of sarcomas.
Gartland A, Pasello M, Lézot F, Lamoureux F. Gartland A, et al. Among authors: lamoureux f. Front Endocrinol (Lausanne). 2023 Jan 18;14:1137736. doi: 10.3389/fendo.2023.1137736. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742406 Free PMC article. No abstract available.
Origin and Therapies of Osteosarcoma.
Moukengue B, Lallier M, Marchandet L, Baud'huin M, Verrecchia F, Ory B, Lamoureux F. Moukengue B, et al. Among authors: lamoureux f. Cancers (Basel). 2022 Jul 19;14(14):3503. doi: 10.3390/cancers14143503. Cancers (Basel). 2022. PMID: 35884563 Free PMC article. Review.
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.
Lavaud M, Mullard M, Tesfaye R, Amiaud J, Legrand M, Danieau G, Brion R, Morice S, Regnier L, Dupuy M, Brounais-Le Royer B, Lamoureux F, Ory B, Rédini F, Verrecchia F. Lavaud M, et al. Among authors: lamoureux f. Cells. 2021 Aug 31;10(9):2268. doi: 10.3390/cells10092268. Cells. 2021. PMID: 34571917 Free PMC article.
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.
Lallier M, Marchandet L, Moukengue B, Charrier C, Baud'huin M, Verrecchia F, Ory B, Lamoureux F. Lallier M, et al. Among authors: lamoureux f. Cells. 2021 Mar 30;10(4):754. doi: 10.3390/cells10040754. Cells. 2021. PMID: 33808130 Free PMC article. Review.
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.
Marchandet L, Lallier M, Charrier C, Baud'huin M, Ory B, Lamoureux F. Marchandet L, et al. Among authors: lamoureux f. Cancers (Basel). 2021 Feb 8;13(4):683. doi: 10.3390/cancers13040683. Cancers (Basel). 2021. PMID: 33567616 Free PMC article. Review.
56 results